title: A response-guided approach based on HBsAg kinetics may identify patients with the greatest chance of success.
authors.affiliation: Hôpital Européen, Laboratoire Alphabio, Marseille, France. Electronic address: philippe.halfon@alphabio.fr.
authors.forename: Philippe
authors.initials: P
authors.lastname: Halfon
authors.affiliation: Hôpital Européen, Laboratoire Alphabio, Marseille, France.
authors.forename: Guillaume
authors.initials: G
authors.lastname: Pénaranda
authors.affiliation: Institut Arnault Tzanck, Saint Laurent du Var, France.
authors.forename: Denis
authors.initials: D
authors.lastname: Ouzan
mesh_terms: D005260:Female; D006147:Guanine / Q000031:analogs & derivatives*; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D006513:Hepatitis B e Antigens / Q000097:blood*; D006515:Hepatitis B virus; D019694:Hepatitis B, Chronic; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage*; D008297:Male; D011092:Polyethylene Glycols / Q000008:administration & dosage*
chemical_list: D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D016898:Interferon-alpha; D011092:Polyethylene Glycols; D006147:Guanine